研究実績

《研究業績目録》特任准教授 吉川 悦次

学術論文(原著)

  1. Onishi Y, Isobe T, Ito M, Hashimoto F, Omura T, Yoshikawa E. :Performance evaluation of dedicated brain PET scanner with motion correction system. Ann Nucl Med. 2022 Aug;36(8):746-755. doi: 10.1007/s12149-022-01757-1. Epub 2022 Jun 13. PMID: 35698016 (IF:2.258)
  2. Inubushi T, Ito M, Mori Y, Futatsubashi M, Sato K, Ito S, Yokokura M, Shinke T, Kameno Y, Kakimoto A, Kanno T, Okada H, Ouchi Y*, Yoshikawa E.: Neural correlates of head restraint: Unsolicited neuronal activation and dopamine release. Neuroimage. 2021 Jan 1;224:117434. doi: 10.1016/j.neuroimage.2020.117434. Epub 2020 Oct 8. PMID: 33039616 (IF:5.812)
  3. Terada T, Obi T, Bunai T, Matsudaira T, Yoshikawa E, Ando I, Futatsubashi M, Tsukada H, Ouchi Y*.: In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease. Neurology. 2020 Apr 14;94(15):e1592-e1604.doi: 10.1212/WNL.0000000000009249. Epub 2020 Mar 5. (IF:8.689)
  4. Yokokura M, Takebayashi K, Takao A, Nakaizumi K, Yoshikawa E, Futatsubashi M, Suzuki K, Nakamura K, Yamasue H, Ouchi Y*.: In vivo imaging of dopamine D1 receptor and activated microglia in attention-deficit/hyperactivity disorder: a positron emission tomography study.: Mol Psychiatry. 2020 May 21. doi: 10.1038/s41380-020-0784-7. Online ahead of print. (IF:11.973)
  5. Yokokura M, Terada T, Bunai T, Nakaizumi K, Kato Y, Yoshikawa E, Futatsubashi M, Suzuki K, Yamasue K, Ouchi Y*.: Alterations in serotonin transporter and body image-related cognition in anorexia nervosa. NeuroImage Clinical. 2019;23:101928. doi: 10.1016/j.nicl.2019.101928. Epub 2019 Jul 3. (IF: 3.943)
  6. Terada T, Yokokura M, Obi T, Bunai T, Yoshikawa E, Ando I, Shimada H, Suhara T, Higuchi M, Ouchi Y*.: In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease. J Neurol. 2019 Sep;266(9):2186-2196. doi: 10.1007/s00415-019-09400-2. Epub 2019 May 28. (IF: 4.204)
  7. Bunai T, Kakimoto A, Yoshikawa E, Terada T, Ouchi Y*.: Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease. J Alzheimers Dis. 2019;69(2):529-538.doi: 10.3233/JAD-181188. (IF: 3.517)
  8. Bunai T, Terada T, Kono S, Yokokura M, Yoshikawa E, Futatsubashi M, Miyajima H, Ouchi Y*.: Neuroinflammation following disease modifying therapy in multiple sclerosis: A pilot positron emission tomography study. J Neurol Sci. 2018 Feb 15;385:30-33. doi: 10.1016/j.jns.2017.12.004. Epub 2017 Dec 6. (IF: 2.651)
  9. Nakaizumi K, Ouchi Y*, Terada T, Yoshikawa E, Kakimoto A, Isobe T, Bunai T, Yokokura M, Suzuki K, Magata Y.: In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease. J Alzheimers Dis. 2018;61(4):1355-1365. doi: 10.3233/JAD-170591. (IF: 3.517)
  10. Kikuchi M, Takahashi T, Hirosawa T, Oboshi Y, Yoshikawa E, Miyabe Y, Ouchi Y*.: The Lateral Occipito-temporal Cortex Is Involved in the Mental Manipulation of Body Part Imagery. Front Hum Neurosci. 2017 Apr 11;11:181. doi: 10.3389/fnhum.2017.00181. eCollection 2017. (IF: 2.87)
  11. Yokokura M, Terada T, Bunai T, Nakaizumi K, Takebayashi K, Iwata Y, Yoshikawa E, Futatsubashi M, Suzuki K, Mori N, Ouchi Y*.: Depiction of microglial activation in aging and dementia: Positron emission tomography with [ 11 C]DPA713 versus [ 11 C]( R)PK11195. J Cereb Blood Flow Metab. 2017 Mar;37(3):877-889.doi: 10.1177/0271678X16646788. Epub 2016 Jul 21. (IF: 6.04)
  12. Fuaki M, Hirosawa T, Kikuchi M, Ouchi Y*, Takahashi T, Yoshimura Y, Miyagishi Y, Kosaka H, Yokokura M, Yoshikawa E, Bunai T, Miyabe Y.: Oxytocin effects on emotional response to others' faces via serotonin system in autism: A pilot study. Psychiatry Res Neuroimaging. 2017 Sep 30;267:45-50. (IF:2.4)
  13. Hirosawa T, Kikuchi M, Ouchi Y*, Takahashi T, Yoshimura Y, Kosaka H, Furutani N, Hiraishi H, Fukai M, Yokokura M, Yoshikawa E, Bunai T, Minabe Y.: A pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorder. Autism Res. 2017 May;10(5):821-828. doi: 10.1002/aur.1761. Epub 2017 Mar 7. (IF: 3.697)
  14. Terada T, Yokokura M, Yoshikawa E, Futatsubashi M, Kono S, Konishi T, Miyajima H, Hasizume T, Ouchi Y*.: Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study. Ann Nucl Med. 2016 Oct;30(8):579-87. doi: 10.1007/s12149-016-1099-2. Epub 2016 Jun 14. (IF: 1.648)
  15. Oboshi Y, Kikuchi M, Terada T, Yoshikawa E, Bunai T, Ouchi Y*.: Alterations in Phase-Related Prefrontal Activation During Cognitive Tasks and Nicotinic α4β2 Receptor Availability in Alzheimer's Disease. J Alzheimers Dis. 2016 May 30;53(3):817-30. doi: 10.3233/JAD-151165. (IF: 3.517)
  16. Terada T, Kakimoto A, Yoshikawa E, Kono S, Bunai T, Hosoi Y, Sakao-Suzuki M, Konishi T, Miyajima H, Ouchi Y*.: The Possible Link between GABAergic Dysfunction and Cognitive Decline in a Patient with Idiopathic Hypoparathyroidism. Intern Med. 2015;54(17):2245-50. doi: 10.2169/internalmedicine.54.4295. Epub 2015 Sep 1. (IF: 0.956)
  17. Okada H, Ouchi Y*, Ogawa M, Futatsubashi M, Saito Y, Yoshikawa E, Terada T, Oboshi Y, Tsukada H, Ueki T, Watanabe M, Yamashita T, Magata Y.: Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology. Brain. 2013 Oct;136(Pt 10):3004-17. doi: 10.1093/brain/awt195. Epub 2013 Aug 24. (IF: 11.814)
  18. Nozaki T, Sugiyama K, Yagi S, Yoshikawa E, Kanno T, Asakawa T, Ito T, Terada T, Namba H, Ouchi Y*.: Effect of subthalamic nucleus stimulation during exercise on the mesolimbocortical dopaminergic region in Parkinson's disease: a positron emission tomography study. J Cereb Blood Flow Metab. 2013 Mar;33(3):415-21. doi: 10.1038/jcbfm.2012.183. Epub 2012 Dec 5. (IF: 6.04)
  19. Oboshi Y, Ouchi Y*, Yagi S, Kono S, Nakai N, Yoshikawa E, Futatsubashi M, Terada T, Kim K, Harada K.: In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study. J Cereb Blood Flow Metab. 2012 Apr;32(4):654-62. doi: 10.1038/jcbfm.2011.201. Epub 2012 Jan 11. (IF: 6.04)
  20. Yamamoto S, Ouchi Y*, Nakatsuka D, Tahara T, Mizuno K, Tajima S, Onoe H, Yoshikawa E, Tsukada H, Iwase M, Yamaguti K, Kuratsune H, Watanabe Y.: Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor. PLoS One. 2012;7(12):e51515. doi: 10.1371/journal.pone.0051515. Epub 2012 Dec 11. (IF: 2.776)
  21. Kikuchi M, Hirosawa T, Yokokura M, Yagi S, Mori N, Yoshikawa E, Yoshihara Y, Sugihara G, Takebayashi K, Iwata Y, Suzuki K, Nakamura K, Ueki T, Minabe Y, Ouchi Y*.: Effects of brain amyloid deposition and reduced glucose metabolism on the default mode of brain function in normal aging. J Neurosci. 2011 Aug 3;31(31):11193-9. doi: 10.1523/JNEUROSCI.2535-11.2011. (IF: 6.074)
  22. Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, Wakuda T, Sugihara G, Takebayashi K, Suda S, Iwata Y, Ueki T, Tsuchiya KJ, Suzuki K, Nakamura K, Ouchi Y*.: In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):343-51. doi: 10.1007/s00259-010-1612-0. Epub 2010 Sep 16. (IF: 7.182)
  23. Kakimoto A, Kamekawa Y, Ito S, Yoshikawa E, Okada H, Nishizawa S, Minoshima S, Ouchi Y*.: New computer-aided diagnosis of dementia using positron emission tomography: brain regional sensitivity-mapping method. PLoS One. 2011;6(9):e25033. doi: 10.1371/journal.pone.0025033. Epub 2011 Sep 26. (IF: 2.776)
  24. Yagi S, Yoshikawa E, Futatsubashi M, Yokokura M, Yoshihara Y, Torizuka T, Ouchi Y*.: Progression from unilateral to bilateral parkinsonism in early Parkinson disease: implication of mesocortical dopamine dysfunction by PET. J Nucl Med. 2010 Aug;51(8):1250-7. doi: 10.2967/jnumed.110.076802. Epub 2010 Jul 21. (IF: 7.354)
  25. Nakamura K, Sekine Y, Ouchi Y*, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K, Matsuzaki H, Suda S, Sugiyama T, Takei N, Mori N.: Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry. 2010 Jan;67(1):59-68. doi: 10.1001/archgenpsychiatry.2009.137. (IF: 15.916)
  26. Tajima S, Yamamoto S, Tanaka M, Kataoka Y, Iwase M, Yoshikawa E, Okada H, Onoe H, Tsukada H, Kuratsune H, Ouchi Y*, Watanabe Y.: Medial orbitofrontal cortex is associated with fatigue sensation. Neurol Res Int. 2010;2010:671421. doi: 10.1155/2010/671421. Epub 2010 Jun 10. (IF: 1.056)
  27. Torizuka T, Tanizaki Y, Kanno T, Futatsubashi M, Yoshikawa E, Okada H, Ouchi Y*.: Single 20-second acquisition of deep-inspiration breath-hold PET/CT: clinical feasibility for lung cancer. J Nucl Med. 2009 Oct;50(10):1579-84. doi: 10.2967/jnumed.109.064246. Epub 2009 Sep 16. (IF: 7.354)
  28. Ouchi Y*, Yoshikawa E, Futatsubashi M, Yagi S, Ueki T, Nakamura K.: Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease. J Nucl Med. 2009 Aug;50(8):1260-6. doi: 10.2967/jnumed.109.063008. Epub 2009 Jul 17. (IF: 7.354)
  29. Sekine Y, Ouchi Y*, Sugihara G, Takei N, Yoshikawa E, Nakamura K, Iwata Y, Tsuchiya KJ, Suda S, Suzuki K, Kawai M, Takebayashi K, Yamamoto S, Matsuzaki H, Ueki T, Mori N, Gold MS, Cadet JL.: Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci. 2008 May 28;28(22):5756-61. doi: 10.1523/JNEUROSCI.1179-08.2008. (IF: 6.074)
  30. Nakayama T, Ouchi Y*, Yoshikawa E, Sugihara G, Torizuka T, Tanaka K.: Striatal D2 receptor availability after shunting in idiopathic normal pressure hydrocephalus. J Nucl Med. 2007 Dec;48(12):1981-6. Epub 2007 Nov 15. (IF: 7.354)
  31. Ouchi Y*, Nakayama T, Kanno T, Yoshikawa E, Shinke T, Torizuka T.: In vivo presynaptic and postsynaptic striatal dopamine functions in idiopathic normal pressure hydrocephalus. J Cereb Blood Flow Metab. 2007 Apr;27(4):803-10. Epub 2006 Aug 16. (IF: 6.04)
  32. Ouchi Y*, Kanno T, Okada H, Yoshikawa E, Shinke T, Nagasawa S, Minoda K, Doi H.: Changes in cerebral blood flow under the prone condition with and without massage. Neurosci Lett. 2006 Oct 23;407(2):131-5. Epub 2006 Sep 14. (IF: 2.173)
  33. Sekine Y, Ouchi Y*, Takei N, Yoshikawa E, Okada H, Minabe Y, Nakamura K, Suzuki K, Iwata Y, Tsuchiya KJ, Sugihara G, Mori N.: Perospirone is a new generation antipsychotic: evidence from a positron emission tomography study of serotonin 2 and D2 receptor occupancy in the living human brain. J Clin Psychopharmacol. 2006 Oct;26(5):531-3. (IF: 2.977)
  34. Nakamura F*, Kanno T, Okada H, Yoshikawa E, Andou I, Futatsubashi M, Shinke T, Ouchi Y, Torizuka T.: [Measurement of radiation exposure to a PET institution driver from patients injected with FDG]. [Article in Japanese]日本語 [Nihon Hoshasen Gijutsu Gakkai Zasshi.]日本放射線技術学会雑誌 2006 Aug 20;62(8):1105-10. (IF: -)
  35. Torizuka T, Nakamura F, Takekuma M, Kanno T, Ogusu T, Yoshikawa E, Okada H, Maeda M, Ouchi Y*.: FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer. Nucl Med Commun. 2006 Jun;27(6):481-7. (IF: 1.465)
  36. Ohmae E, Ouchi Y*, Oda M, Suzuki T, Nobesawa S, Kanno T, Yoshikawa E, Futatsubashi M, Ueda Y, Okada H, Yamashita Y.: Cerebral hemodynamics evaluation by near-infrared time-resolved spectroscopy: correlation with simultaneous positron emission tomography measurements. Neuroimage. 2006 Feb 1;29(3):697-705. Epub 2005 Sep 13. (IF:5.812)
  37. Sekine Y, Ouchi Y*, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, Tsuchiya KJ, Tsukada H, Iyo M, Mori N.: Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry. 2006 Jan;63(1):90-100. (IF: 15.916)
  38. Nakamura F,* Kanno T, Torizuka T, Yoshikawa E, Ouchi Y.: [Physical property of emission data in simultaneous emission/transmission acquisition: evaluation for clinical application]. [Article in Japanese]日本語 [Nihon Hoshasen Gijutsu Gakkai Zasshi.] 日本放射線技術学会雑誌 2005 Jun 20;61(6):826-32. (IF: -)
  39. Ouchi Y*, Kanno T, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Kaneko M.: Neural substrates in judgment process while playing go: a comparison of amateurs with professionals. Brain Res Cogn Brain Res. 2005 May;23(2-3):164-70. Epub 2004 Nov 10. (IF: 2.733)
  40. Ouchi Y*, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T.: Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol. 2005 Feb;57(2):168-75. (IF: 9.496)
  41. Ouchi Y*, Yoshikawa E, Kanno T, Futatsubashi M, Sekine Y, Okada H, Torizuka T, Tanaka K.: Orthostatic posture affects brain hemodynamics and metabolism in cerebrovascular disease patients with and without coronary artery disease: a positron emission tomography study. Neuroimage. 2005 Jan 1;24(1):70-81. (IF: 5.812)
  42. Yamamoto S, Ouchi Y*, Onoe H, Yoshikawa E, Tsukada H, Takahashi H, Iwase M, Yamaguti K, Kuratsune H, Watanabe Y.: Reduction of serotonin transporters of patients with chronic fatigue syndrome. Neuroreport. 2004 Dec 3;15(17):2571-4. (IF: 1.146)
  43. Ouchi Y*, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Kaneko M.: Activation in the premotor cortex during mental calculation in patients with Alzheimer's disease: relevance of reduction in posterior cingulate metabolism. Neuroimage. 2004 May;22(1):155-63. (IF: 5.812)
  44. Torizuka T, Nakamura F, Kanno T, Futatsubashi M, Yoshikawa E, Okada H, Kobayashi M, Ouchi Y*.: Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):22-8. Epub 2003 Oct 22. (IF: 7.182)
  45. Sekine Y, Minabe Y, Ouchi Y*, Takei N, Iyo M, Nakamura K, Suzuki K, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Mori N.: Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry. 2003 Sep;160(9):1699-701. (IF: 13.655)
  46. Torizuka T, Kanno T, Futatsubashi M, Okada H, Yoshikawa E, Nakamura F, Takekuma M, Maeda M, Ouchi Y*.: Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. J Nucl Med. 2003 Jul;44(7):1051-6. (IF: 7.354)
  47. Iwase M, Ouchi Y*, Okada H, Yokoyama C, Nobezawa S, Yoshikawa E, Tsukada H, Takeda M, Yamashita K, Takeda M, Yamaguti K, Kuratsune H, Shimizu A, Watanabe Y.: Neural substrates of human facial expression of pleasant emotion induced by comic films: a PET Study. Neuroimage. 2002 Oct;17(2):758-68. (IF: 5.812)
  48. Torizuka T, Nobezawa S, Kanno T, Futatsubashi M, Yoshikawa E, Okada H, Takekuma M, Maeda M, Ouchi Y*.: Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose. Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):797-803. Epub 2002 Mar 19. (IF: 7.182)
  49. Ouchi Y*, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Sakamoto M.: Effect of simple motor performance on regional dopamine release in the striatum in Parkinson disease patients and healthy subjects: a positron emission tomography study. J Cereb Blood Flow Metab. 2002 Jun;22(6):746-52. (IF: 6.04)
  50. Watanabe M, Shimizu K, Omura T, Takahashi M, Kosugi T, Yoshikawa E, Sato N, Okada H, Yamashita T*: A New High-Resolution PET Scanner Dedicated to Brain Research. IEEE Transaction on Nuclear Science. 2002; Vol.49, No.3 634-639 (IF: 1.92)
  51. Ouchi Y*, Nobezawa S, Yoshikawa E, Futatsubashi M, Kanno T, Okada H, Torizuka T, Nakayama T, Tanaka K.: Postural effects on brain hemodynamics in unilateral cerebral artery occlusive disease: a positron emission tomography study. J Cereb Blood Flow Metab. 2001 Sep;21(9):1058-66. (IF: 6.04)
  52. Sekine Y, Iyo M, Ouchi Y*, Matsunaga T, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Takei N, Mori N.: Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry. 2001 Aug;158(8):1206-14. (IF: 13.655)
  53. Ouchi Y*, Okada H, Yoshikawa E, Futatsubashi M, Nobezawa S.: Absolute changes in regional cerebral blood flow in association with upright posture in humans: an orthostatic PET study. J Nucl Med. 2001 May;42(5):707-12. (IF: 7.354)
  54. Ouchi Y*, Kanno T, Okada H, Yoshikawa E, Futatsubashi M, Nobezawa S, Torizuka T, Tanaka K.: Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease. Brain. 2001 Apr;124(Pt 4):784-92. (IF: 11.814)
  55. Torizuka T, Nobezawa S, Momiki S, Kasamatsu N, Kanno T, Yoshikawa E, Futatsubashi M, Okada H, Ouchi Y*.: Short dynamic FDG-PET imaging protocol for patients with lung cancer. Eur J Nucl Med. 2000 Oct;27(10):1538-42. (IF: 7.182)
  56. Ouchi Y*, Kanno T, Okada H, Yoshikawa E, Futatsubashi M, Nobezawa S, Torizuka T, Sakamoto M.: Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study. Ann Neurol. 1999 Nov;46(5):723-31. (IF:9.496)
  57. Hasebe H, Oyamada H, Kinomura S, Kawashima R, Ouchi Y*, Nobezawa S, Tsukada H, Yoshikawa E, Ukai K, Takada R, Takagi M, Abe H, Fukuda H, Bando T.: Human cortical areas activated in relation to vergence eye movements-a PET study. Neuroimage. 1999 Aug;10(2):200-8. (IF: 5.812)
  58. Ouchi Y*, Yoshikawa E, Okada H, Futatsubashi M, Sekine Y, Iyo M, Sakamoto M.: Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography. Ann Neurol. 1999 May;45(5):601-10. (IF: 9.496)
  59. Ouchi Y*, Okada H, Yoshikawa E, Nobezawa S, Futatsubashi M.: Brain activation during maintenance of standing postures in humans. Brain. 1999 Feb;122 ( Pt 2):329-38. (IF: 11.814)
  60. Ouchi Y*, Nobezawa S, Okada H, Yoshikawa E, Futatsubashi M, Kaneko M.: Altered glucose metabolism in the hippocampal head in memory impairment. Neurology. 1998 Jul;51(1):136-42. (IF: 8.689)
  61. Seki C, Okada H, Mori S, Kakiuchi T, Yoshikawa E, Nishiyama S, Tsukada H, Yamashita T.: Application of a beta microprobe for quantification of regional cerebral blood flow with (15)O-water and PET in rhesus monkeys. Ann Nucl Med. 1998 Feb;12(1):7-14. (IF: 1.648)
  62. Watanabe M, Okada H, Shimizu K, Omura T, Yoshikawa E, Kosugi T, Mori S, Yamashita, T.: A high resolution animal PET scanner using compact PS-PMT detectors. Nuclear Science, IEEE Transac Vol.44, No.3, Jun3 1997 1277-1282 (IF: 1.92)
  63. Watanabe M, Uchida H, Okada H, Shimizu K, Satoh N, Yoshikawa E, Ohmura T, Yamashita T, Tanaka E.: A high resolution PET for animal studies. IEEE Trans Med Imaging. 1992;11(4):577-80. (IF: 7.816)
  64. Yamashita T, Uchida H, Okada H, Kurono T, Takemori T, Watanabe M, Shimizu K, Yoshikawa E, Ohmura T, Satoh N, Tanaka E: DEVELOPMENT OF A HIGH RESOLUTION PET. IEEE Transaction on Nuclear Science. 1990; Vol.37, 594-599 (IF: 1.92)
 

総説等

  1. Yoshikawa E, Ouchi Y*, Kanno T, Okada H, Futatsubashi M, Nobezawa S, Torizuka T, Sakamoto M: [11C]Beta-CFT Binding in Perkinson's Disease with and without Dementia Measured by Positron Emission Tomography: Statistical Parametric Mapping Analysis. Academic Press, Physiological Imaging of the Brain with PET. 2001, 377-380 (IF: -)
 

学会発表

  • 吉川悦次・Ordered-Subset EM アルゴリズムを用いたPETデータにおける定量性の検討・日本核医学会・1998年
  • 吉川悦次・痴呆を伴うパーキンソン病患者のドパミントランスポータ結合について-SPMによる検討-・日本核医学会・1999年
  • 吉川悦次・Acetazolamide負荷前後での脳血流量、血液量、平均通過時間のパラメータ変化-OSEMを用いた検討-・日本核医学会・2000年
  • 吉川悦次・15O2ガス一回吸入法による脳酸素代謝測定の計測条件の検討・日本核医学会・2001年
  • 吉川悦次・RI投与後-Transmissionデータを用いた簡便な吸収補正法の検討・日本核医学会・2002年
  • 吉川悦次・Effect of different normal database of FDG-PET images on NEUROSTAT results・光科学技術で拓く脳・精神科学平和探求研究会・2002年
  • 吉川悦次・11C標識薬剤におけるRI投与後Transmissionデータを用いた簡便な吸収補正法の検討・日本核医学会・2003年
  • 吉川悦次・NEUROSTATにおけるH2-15Oと18F-FDG PETの標準脳変換時の誤差の検討・日本核医学会・2004年
  • 吉川悦次・PIB-PETの3D-SSPデータベースの検討・日本核医学会・2009年
  • 吉川悦次・非拘束頭部用PETの検討・日本核医学会・2011年
  • 吉川悦次・非拘束頭部用PETの精度の検討・日本核医学会・2012年
  • 吉川悦次・Study of Fixation-Free Brain PET Measurement・SNMMI・2012年
  • 吉川悦次・Study of Fixation-Free Brain PET・光科学技術で拓く脳・精神科学平和探求研究会・2012年
  • 吉川悦次・Fixation-free brain PET with SiPM(MPPC) based detectors and motion tracking system・光科学技術で拓く脳・精神科学平和探求研究会・2014年
  • 吉川悦次・非拘束頭部用PETによる受容体画像におけるトレーサー結合の正確な推定・日本核医学会・2015年
  • 吉川悦次・Alpha7 nicotinic receptor imaging using a new fixation-free PET system・RSNA・2015年
  • 吉川悦次・Alpha7 nicotinic acetylcholine receptor imaging using a new fixation-free PET system・光科学技術で拓く脳・精神科学平和探求研究会・2016年
  • 吉川悦次・Fixation-free brain PET with motion correction・光科学技術で拓く脳・精神科学平和探求研究会・2018年
  • 吉川悦次・Development of a new brain PET・光科学技術で拓く脳・精神科学平和探求研究会・2020年
  • 吉川悦次・Clinical application of a newly-developed, motion-correction brain PET system・IEEENSSMIC・2023年
  • 吉川悦次・体動補正機能付き頭部用PET装置の開発・日本核医学会・2023年
 
 

《研究業績目録》特任教授 星 詳子

学術論文(原著)

  1. Harada T*, Iwabuchi T, Senju A, Nakayasu C, Nakahara R, Tsuchiya K. Hoshi Y. Neural mechanisms underlying rule selection based on response evaluation: a near-infrared spectroscopy study. Sci. Rep. 12, 20696, 2022. (IF: 4.379)
  2. Takamizu Y*, Umemura M, Yajima H, Abe M, Hoshi Y. Deep learning of diffuse optical tomography based on time-domain radiative transfer equation. Appl. Sci. 12: 12511, 2022. (IF: 2.838)
  3. Shinba T*, Karuya N, Matsuda S, Arai M, Itokawa M, Hoshi Y. Near-infrared time-resolved spectroscopy shows anterior prefrontal blood volume reduction in schizophrenia but not in major depressive disorder. Sensors 22, 1594, 2022. (IF: 3.576)
  4. Yajima H*, Abe M, Umemura M, Takamizu Y, Hoshi Y. TRINITY: A three-dimensional time-dependent radiative transfer code for in-vivo near-infrared imaging. J Quant Spectro Rad Trans 277: 107948, 2022. (IF: 2.468)
  5. Mimura T, Okawa S, Kawaguchi H, Tanikawa Y, Hoshi Y*. Imaging the human whole thyroid using three-dimensional diffuse optical tomography: a preliminary study. Appl Sci 11: 1670, 2021. (IF: 2.69)
  6. Machida M*, Hoshi Y, Kagawa K, Takada K. Decay behavior and optical parameter identification for spatial-frequency domain imaging by the radiative transport equation. J Opt Soc Am A 37: 2020-2031, 2020. (IF: 2.106)
  7. Capart A, Ikegaya S, Okada E, Machida M, Hoshi Y*: Experimental tests of indicators for the degree of validness of the diffusion approximation. J Phys Commun 5, 025012, 2021.
  8. Hoshi Y*, Tanikawa Y, Okada E, Kawaguchi H, Shimizu K, Nemoto M, Kodama T. Watanabe M: In situ estimation of optical properties of rat and monkey brains using femtosecond time-resolved measurements. Sci Rep 9: 9165, 2019 (IF: 4.38)
  9. Jiang Y, Hoshi Y, Nakamura G, Machida M*: A hybrid inversion scheme combining Marcov Chain Monte Carlo and iterative methods for determining optical properties of random media. Appl Sci, 9: 3500, 2019. (IF: 2.69)
  10. Fujii H*, Yamada Y, Hoshi Y, Kobayashi K, Watanabe M: Numerical study of light scattering in the human neck for diagnosis of thyroid cancers by optical tomography, J Comput Phys 374: 591-604, 2018 (IF: 2.864)
  11. Fujii H*, Yamada Y, Hoshi Y, Okawa S, Kobayashi K, Watanabe M: Light propagation model of titanium dioxide suspensions in water using the radiative transfer equation. React Kinet Mech Catl 123: 439-453, 2018. (IF: 2.081)
  12. Fujii H*, Yamada Y, Kobayashi K, Watanabe M, Hoshi Y: Modeling of light propagation in the human neck for diagnoses of thyroid cancers by diffuse optical tomography. Int J Numer Methods Biomed Eng, 33: e2826 1-12, 2017. (IF: 2.74)
  13. Fujii H*, Okawa S, Yamada Y, Hoshi Y, Watanabe M: Renormalization of the highly forward-peaked phase function using the double exponential formula for radiative transfer. J Math Chem, 54: 2048- 2061, 2016. (IF: 2.468)
  14. Kida I*, Hoshi Y: Right ventrolateral prefrontal cortex involvement in the integration of emotional processing: Parametric mediation analysis of fMRI. Neurosci Lett 615: 92-97, 2016 (IF: 3.046)
  15. Fujii H*, Okawa S, Nadamoto K, Okada E, Yamada Y, Hoshi Y, Watanabe M: Numerical modeling of photon migration in human neck based on the radiative transport equation. J Appl Nonlinear Dynam 5: 117–125, 2016. (IF: 0.588)
  16. Sieno LD*, Wabnitz H, Pifferil A, Mazurenka M, Hoshi Y, Mora AD, Contini D, Boso G, Becker W, Martelli F, Tosi A, Macdonald R: Characterization of a time-resolved non-contact scanning diffuse optical imaging system exploiting fast-gated SPAD detection. Rev Sci Instrum, 87: 035118, 2016. (IF: 1.78)
  17. Kohno S*, Hoshi Y: Spatial distributions of hemoglobin signals from superficial layers in the forehead during a verbal-fluency task. J. Biomed Opt, 21: 066009, 2016. (IF: 3.17)
  18. Kohno S*, Noriuchi M, Iguchi Y, Kikuchi Y, Hoshi Y: Emotional discrimination during viewing unpleasant pictures: timing in human anterior ventrolateral prefrontal cortex and amygdala. Front Hum Neurosci, 10: 51. 2015. (IF: 3.169)
  19. Fujii H*, Okawa S, Yamada Y, Hoshi Y: Hybrid model of light propagation in random media based on the time-dependent radiative transfer and diffusion equations. J Quant Spectro Rad Trans 147: 145-154, 2014 (IF = 2.468)
  20. Oonishi S*, Hori S, Hoshi Y, Seiyama A: Influence of subjective happiness on the prefrontal brain activity: an fNIRS study. Adv. Exp. Med. Biol. 2812: 287-293, 2014. (IF=2.622)
  21. Okawa S.*, Yano A, Uchida K, Mitsui Y, Yoshida Y, Takekoshi M, Marjono A, Gao F, Hoshi Y, Kida I, Masamoto K, Yamada Y: Phantom and Mouse Experiments of Time-domain Fluorescence Tomography Using Total Light Approach. Biomed Opt Exp 4: 635-651, 2013. (IF=3.732)
  22. Sato C, Shimada M. Tanikawa Y, Hoshi Y*: Estimating the absorption coefficient of the bottom layer in four-layered turbid mediums based on the time-domain depth sensitivity of near-infrared light reflectance. J Biomed Opt 18: 09705-1-9. 2013. (IF=3.17)
  23. Doi N*, Hoshi Y, Itokawa M, Yoshikawa T, Ichikawa T, Usui C, Tachikawa H: Paradox of schizophrenia genetics: do we need a paradigm shift? Behav Brain Funct 8: 28, 2012. (IF: 3.759)
  24. Okawa S*, Endo Y, Hoshi Y, Yamada Y: Reduction of Poisson noise in measured time-resolved data for time-domain diffuse optical tomography. Med Biol Eng Comput 50: 69-78, 2012. (IF = 2.602)
  25. Nemoto M*, Hoshi Y, Sato C, Iguchi Y, Hashimoto I, Kohno, E, Hirano T, Terakawa S: Diversity of neural-hemodynamic relationships associated with differences in cortical processing during bilateral somatosensory activation in rats. NeuroImage 59: 3325-3338, 2012. (IF=6.556)
  26. Nishihara K*, Horiuchi S, Kikuchi S, Hoshi Y: The relationship between infants’ circadian rest-activity rhythm and mothers’ circadian rest-activity rhythm pre- and postparatum, with a comparison to an infant with free-running rhythm. Chronobiol Int 29: 363-370, 2012. (IF=3.154)
  27. Hoshi Y*, Huang J, Kohri S, Iguchi Y, Naya M, Okamoto T, Ono S: Recognition of human emotions from cerebral blood flow changes in the frontal region: a study with event-related near-infrared spectroscopy. J Neuroimaging 21: e94-e101, 2011. (IF =2.486)
  28. Kida I*, Iguchi Y, Hoshi Y: Blood oxygenation level-dependent functional magnetic resonance imaging of bilateral but asymmetrical responses to gustatory stimulation in the rat insular cortex. NeuroImage, 56:1520-1525, 2011. (IF =6.556)
  29. Wada M, Hoshi Y, Iguchi Y, Kida I*: Near-infrared spectroscopic study on the effects of chewing on short-term memory. Appetite 57:749-752, 2011. (IF=3.868)
  30. Okawa S*, Hoshi Y, Yamada Y: Improvement of image quality of time-domain diffuse optical tomography with lp sparsity regularization. Biomed Opt Express 2: 3334-3348, 2011. (IF=3.732)
  31. Fukuzawa R, Okawa S*, Matsuhashi S, Kusaka T, Tanikawa Y, Hoshi Y, Yamada Y: Reduction of image artifacts induced by change in the optode coupling in time-resolved diffuse optical tomography. J Biomed Opt 16:116022, 2011. (IF=3.17)
  32. Goto K, Hoshi Y*, Sata M, Kawahara M, Takahashi M, Murohashi M: The role of the prefrontal cortex in the cognitive control of reaching movements - a near-infrared spectroscopy study. J Biomed Opt 16: 127003, 2011. (IF=3.17)
  33. Uchida K, Okawa S*, Matsuhashi S, Hoshi Y, Yamada Y: Effective optode configuration for the image reconstruction in diffuse optical tomography. Medical Laser Application 25: 154-160, 2010.
  34. Shimada M, Sato C, Hoshi Y, Yamada Y*: Estimation of the absorption coefficients of two-layered media by a simple method using spatially and time-resolved reflectance. Phys Med Biol 54: 5057-5071, 2009. (IF =3.609)
  35. Doi N*, Hoshi Y, Itokawa M, Usui C, Yoshikawa T, Tachikawa H: Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint. PLoS ONE 4: e7799, 2009. (IF=3.24)
  36. Sato C*, Yamguchi T, Mitsuru S, Ota S, Yu I, Iguchi Y, Nemoto M, Hoshi Y: Intraoperative monitoring of depth-dependent hemoglibin concentration changes during carotid endarterectomy by time-resolved spectroscopy. Appl Opt 46: 2785-2792, 2007. (IF = 1.98)
  37. Iguchi Y*, Hoshi Y, Nemoto M, Taira M, Hashimoto I: Co-activation of the secondary somatosensory and auditory cortices facilitates frequency discrimination of vibrotactile stimuli. Neuroscience 148: 461-472, 2007. (IF = 3.59)
  38. Doi N*, Itokawa M, Hoshi Y, Arai M, Furukawa A, Ujike H, Sora I, Yoshikawa T: A resistance gene in disguise for schizophrenia? Am J Med Genet B (Neuropsychiatr Genet) 144: 165-173, 2007. (IF =3.568)
  39. Doi N*, Hoshi Y: Persistence problem in schizophrenia and mitochondrial DNA. Am J Med Genet B (Neuropsychiatr Genet) 144: 1-4, 2007. (IF =3.568)
  40. Matsuda T*, Okuyama K, Cho K, Okajima S, Kobayashi Y, Hoshi Y, Kobayashi K: Cerebral hemodynamics during the induction of antenatal periventricular leukomalasia hemorrhagic hypotention in chronically instrumented fetal sheep. Am J Obstet Gynecol 194: 1057-1063, 2006. (IF = 8.661)
  41. Hoshi Y*, Shinba T, Sato C, Doi N: Resting hypofrontality in schizophrenia: a study using near-infrared time-resolved spectroscopy. Schizophr Res 84: 411-420, 2006. (IF = 4.939)
  42. Sitaram R*, Zhang H, Guan C, Thulasidas M, Hoshi Y, Ishikawa A, Shimizu K, Birbaumer N: Temporal classification of multi-channel near infrared spectroscopy signals of motor imagery for developing a brain-computer interface. NeuroImage 34: 1416-1427, 2006. (IF = 6.556)
  43. Iguchi Y*, Hoshi Y, Tanosaki M, Taira M, Hashimoto I: Attention induces reciprocal activity in human somatosensory cortex enhancing relevant- and suppressing irrelevant inputs from fingers. Clin Neurophysiol 116: 1077-1087, 2005. (IF = 3.708)
  44. Hoshi Y*, Shimada M, Sato C, Iguchi Y: Reevaluation of near-infrared light propagation in the adult human head: implications for functional near-infrared spectroscopy. J Biomed Opt 10: 064032, 2005. (IF =3.17)
  45. Sato C*, Shimada M, Hoshi Y, Yamada Y: Extraction of depth-dependent signals from time-resolved reflectance in layered turbid media. J Biomed Opt 10: 064008, 2005. (IF =3.17)
  46. Shimada M*, Hoshi Y, Yamada Y: Simple algorithm for the measurement of absorption coefficients of a two-layered medium by spatially and time-resolved reflectance. Appl Opt 44: 7554-7563, 2005. (IF = 1.98)
  47. Shinba T*, Nagano M, Karia N, Ozawa N, Shinohara T, Shimosato S, Hoshi Y: Near-infrared spectrscopy analysis of frontal lobe dysfunction in schizophrenia. Biol Psychiat 55: 154-164, 2004. (IF = 13.382)
  48. Tanosaki M*, Sato C, Iguchi Y, Shimada M, Hoshi Y: Effect of stimulus frequency on human cerebral hemodynamic responses to electric median nerve stimulation: a near-infrared spectroscopic study. Neurosci Lett 352: 1-4, 2004. (IF = 3.046)
  49. Kobayashi N, Hoshi Y*, Tamura M: A perfused rat brain model maintaining the connection between the central and peripheral nervous systems. J Neurosci Meth 132: 191-198, 2004. (IF = 2.39)
  50. Hoshi Y*, Tsou BH, Billock VA, Tanosaki M, Iguchi Y, Shimada M, Shinba T, Yamada Y, Oda I: Spatiotemporal characteristics of hemodynamic changes in the human lateral prefrontal cortex during working memory tasks. NeuroImage 20: 1493-1504, 2003. (IF = 6.556)
  51. Tanosaki M*, Suzuki A, Kimura T, Takino R, Haruta Y, Hoshi Y, Hashimoto I: Contribution of primary somatosensory area 3b to somatic cognition: a neuromagnetic study. NeuroReport 13: 1519-522, 2002. (IF = 1.837)
  52. Tanosaki M*, Suzuki A, Takino R, Kimura T, Iguchi Y, Kurobe Y, Haruta Y, Hoshi Y, Hashimoto I: Neural mechanisms for generation of tactile interference effects on somatosensory evoked magnetic fields in human. Clin Neurophysiol 113: 672-680, 2002. (IF = 3.708)
  53. Kohri S, Hoshi Y, Tamura M*, Katoh C, Kuge U, Tamaki N: Quantitative evaluation of the relative contribution ratio of cerebral tissue to near-infrared signals in the adult human head - a preliminary study. Physiol Meas 23: 301-312, 2002. (IF = 2.833)
  54. Tanosaki M*, Kimura T, Takino R, Iguchi Y, Suzuki A, Kurobe Y, Haruta Y, Hoshi Y, Hashimoto I: Movement interference attenuates somatosensory high-frequency oscillations: contribution of local axon collaterals of 3b pyramidal neurons. Clin Neurophysiol 113: 993-1000, 2002. (IF = 3.708)
  55. Hoshi Y*, Chen S-J: Regional cerebral blood flow changes associated with emotions in children. Pediatr Neurol 27: 275-281, 2002. (IF =3.372)
  56. Tanosaki M*, Iguchi Y, Takino R, Kimura T, Kurobe Y, Haruta Y, Hoshi Y, Hashimoto I: Somatosensory information processing in area 3b for thumb and middle finger in humans. Int Congr Ser 1232: 203-206, 2002.
  57. Iguchi Y*, Hoshi Y, Tanosaki M, Taira M, Hashimoto I: Selective attention regulates spatial and intensity information processing in the human primary somatosensory cortex. NeuroReport 13: 2335-2339, 2002. (IF = 1.837)
  58. Tanosaki M*, Hoshi Y, Iguchi Y, Oikawa Y, Oda I, Oda M: Variation of temporal characteristics in human cerebral hemodynamic responses to electric median nerve stimulation: a near-infra-red spectroscopic study. Neurosci Lett 316: 75-78, 2001. (IF = 3.046)
  59. Tanosaki M*, Hashimoto I, Iguchi Y, Kimura T, Takino R, Kurobe Y, Haruta Y, Hoshi Y: Specific somatosensory processing in somatosensory area 3b for human thumb: a neuromagnetic study. Clin Neurophysiology 112: 1516-1522, 2001. (IF =3.708)
  60. Hoshi Y*, Kobayashi N, Tamura M: Interpretation of near-infrared spectroscopy signals: a study with a newly developed perfused rat brain model. J Appl Physiol 90: 1657-1662, 2001. (IF =3.531)
  61. Iguchi Y*, Hoshi Y, Hashimoto I: Selective spatial attention induces short-term plasticity in human somatosensory cortex. NeuroReport 12: 3133-3136, 2001. (IF = 1.837)
  62. Hoshi Y*, Oda I, Wada Y, Ito Y, Yamashita Y, Oda M, Ohta K, Yamada Y, Tamura M: Visuospatial imagery is a fruitful strategy for the digit span backward task: a study with near-infrared optical tomography. Brain Res Cogn Brain Res 9: 339-342, 2000. (IF = 3.52)
  63. Hoshi Y*, Kohri S, Matsumoto Y, Cho K, Matsuda T, Okajima S, Fujimoto S: Hemodynamic responses to photic stimulation in neonates. Pediatr Neurol 23: 323-327, 2000. (IF=3.372)
  64. Hoshi Y*, Okuhara H, Nakane S, Hayakawa K, Kobayashi N, Kajii N: Reevaluation of the hypoxic theory as the mechanism of hyperventilation-induced EEG slowing. Pediatr Neurol 21: 638-643, 1999. (IF = 3.372)
  65. Hoshi Y*, Kosaka S. Xie Y, Kohri S, Tamura M: Relationship between fluctuations in the cerebral hemoglobin oxygenation state and neuronal activity under resting conditions in man. Neurosci Lett 245: 147-150, 1998. (IF = 3.046)
  66. Hoshi Y*, Tamura M: Near-infrared optical detection of sequential brain activation in the prefrontal cortex during mental tasks. NeuroImage 5: 292-297, 1997. (IF = 6.556)
  67. Tamura M*, Hoshi Y, Okada F: Localized near-infrared spectroscopy and functional optical imaging of brain activity. Philos T R Soc B 352: 737-742, 1997. (IF =6.237)
  68. Hoshi Y*, Tamura M: Fluctuation in the cerebral oxygenation state during the resting period in functional mapping studies of the human brain. Med Biol Eng Comput 35: 328-330, 1997. (IF = 2.602)
  69. Hoshi Y*, Hazeki O, Kakihana Y, Tamura M: Redox behavior of cytochrome oxidase in the rat brain measured by near-infrared spectroscopy. J Appl Physiol 83: 1842-1845, 1997. (IF = 3.531)
  70. Kuroda S*, Houkin K, Abe H, Hoshi Y, Tamura M: Near-infrared monitoring of cerebral oxygenation state during carotid endarterectomy. Surg Neurol 45: 450-458, 1996. (IF = 1.26)
  71. Kuroda S*, Houkin K, Hoshi Y, Tamura M, Kazumata K, Abe H: Cerebral hypoxia after hyperventilation causes "re-build-up" phenomenon and TIA in childhood moyamoya disease A near-infrared spectroscopy study. Child Nerv Syst 12: 448-453, 1996. (IF=1.475)
  72. Okada F*, Tokumitsu Y, Hoshi Y, Tamura M: Region-dependent asymmetrical or symmetrical variations in the oxygenation and hemodynamics of the brain due to different mental stimuli. Brain Res Cogn Brain Res 2: 215-219, 1995. (IF = 3.252)
  73. Okada F*, Tokumitsu Y, Takahashi N, Hoshi Y, Tamura M. Symmetrical and asymmetrical changes in oxygenation and hemodynamics of brain hemispheres due to coincidental emotional condition. Neuropsychiatr Neuropsychol Behav Neurol, 8: 106-112, 1995. (IF =1.6)
  74. Hoshi Y*, Onoe H, Watanabe Y, Andersson J, Bergström M, Lilija A, Långström B, Tamura M: Non-synchronous behavior of neuronal activity, oxidative metabolism and blood supply during mental tasks in man. Neurosci Lett 172: 129-133, 1994. (IF =3.046)
  75. Hoshi Y*, Mizukami S, Tamura M: Dynamic features of hemodynamic and metabolic changes in the human brain during all-night sleep as revealed by near-infrared spectroscopy. Brain Res 652: 257-262, 1994. (IF=3.52)
  76. Hoshi Y*, Tamura M: Multichannel near-infrared optical imaging of brain activity. Neuroscience Protocols 1: 94-070-04 1-15, 1994.
  77. Okada F*, Tokumitsu Y, Hoshi Y, Tamura M: Impaired interhemispheric integration in brain oxygenation and hemodynamics in schizophrenia. Eur Arch Psychiatry Clin Neurosci 244: 17-25, 1994. (IF =5.27)
  78. Hoshi Y*, Tamura M: Dynamic changes in cerebral oxygenation in chemically induced seizures in rats: udy by near-infrared spectrophotometry. Brain Res 603: 215-221, 1993. (IF=3.52)
  79. Okada F*, Tokumitsu Y, Hoshi Y, Tamura M: Gender-and handedness-related differences of forebrain oxygenation and hemodynmics. Brain Res 601: 337-342, 1993. (IF=3.52)
  80. Hoshi Y*, Tamura M: Dynamic multichannel near-infrared optical imaging of human brain activity. J Appl Physiol 75: 1842-1846, 1993. (IF = 3.531)
  81. Hoshi Y*, Tamura M: Detection of dynamic changes in cerebral oxygenation coupled to neuronal function during mental work in man. Neurosci Lett 150: 5-8, 1993. (IF = 3.046)
  82. Hoshi Y*, Hazeki O, Tamura M: Oxygen dependence of redox state of copper in cytochrome oxidase in vitro. J Appl Physiol 74: 1622-1627, 1993. (IF = 3.531)
 

総説等

  1. Okawa S*, Hoshi Y. A review of image reconstruction algorithms for diffuse optical tomography. Appl. Sci. 13: 5016, 2023. (IF=2.7)
  2. Hoshi Y*, Yamada Y. Overview of diffuse optical tomography and its clinical applications. J Biomed Opt 21: 091312, 2016. (IF=3.17)
  3. Cho YK*, Zheng G, Augustine GJ, Hochbaum D, Cohen A, Knöpfel T, Pisanello F, Pavone FS, Vellekoop IM, Booth MJ, Hu S, Zhu J, Chen Z, Hoshi Y. Roadmap on neurophotonics. J Opt 18: 093007, 2016. (IF=2.516)
  4. Hoshi Y*: Toward the next generation of NIRS. Phil Trans R Soc A 369: 4425-4439, 2011. (IF=4.226).
  5. Hoshi Y*: Functional near-infrared spectroscopy: current status and feature prospects. J Biomed Opt 12: 062106: 2007. (IF =3.17)
  6. Hoshi Y*: Functional near-infrared optical imaging: Utility and limitations in human brain mapping. Psychophysiology, 40: 511-520, 2003. (IF = 3.67)
  7. Tamura M*, Hoshi Y, Nemoto M, Sato C, Kohri S: Quantitative optical imaging of brain activity - human and animal studies. Int Congr Ser 1235: 181-188, 2002
  8. Hoshi Y*, Chen S-J, Tamura M: Spatiotemporal imaging of human brain activity by functional near-infrared spectroscopy. Am Lab 33: 35-39, 2001.
 

著書(英文)

  1. Hoshi Y*: Hemodynamic signals of fNIRS. In: Masamto K, Hirase H, Yamada K. eds. New Horizons in Neurovascular Coupling: A Bridge Between Brain Circulation and Neural Plasticity. Vol 225. PBR, Elsevier, UK, pp153-179, 2016. (IF=2.21)
  2. Hoshi Y*, Shing-Jen Chen: Elucidation of Neuropsychological Mechanisms of Eye Movements Accompanying Cognitive Activity. In: Garza P. ed. Cognitive Control: Development, Assessment and Performance. Nova Science, NY USA, pp31-56, 2016
  3. Doi N*, Hoshi Y, Itokawa M, Yoshikawa T, Ichikawa T: Impact of Epidemiology on Molecular Genetics of Schizophrenia. In: Maria de Lourdes Ribeiro de Souza da Cunha ed., Epidemiology Insights, InTech Rijeka, Croatia, pp113-138, 2012.
  4. Hoshi Y*: Near infrared spectroscopy for studying higher cognition. In: Eduard K, Balázs G, Ernst P eds., Book series of thinking. Vol. I Neural correlates of thinking. Springer, Heiderberg, pp83-93, 2008.
  5. Hoshi Y*, Kohri S, Kobayashi N: Interpretation of increases in deoxy-Hb during functional activation. In: Wu JL, Ito K, Tobimatsu S, Nishida T, Fukuyama H eds., Complex medical engineering. Springer, Tokyo, pp469-479, 2007.
  6. Hoshi Y*, Chen S-J: New dimension of cognitive neuroscience research with near-infrared spectroscopy: free-motion neuroimaging studies. In: Chen FJ ed., Progress in brain mapping research. Nova Science, NY USA, pp205-229, 2006.
  7. Hoshi Y*: Functional near-infrared spectroscopy: potential and limitations in neuroimaging studies. In: Glabus MF ed., Neuroimaging Part A: International review of neurobiology. Elsevier Academic Press, New York, pp238-266, 2005. (IF = 2.183)
  8. Hoshi Y*: Near-infrared optical imaging of the human brain. In: Chen J, Chen ACN, Han J-S, Willis WD eds., Experimental pathological pain: from molecules to brain functions. Science Press, Beijing, pp338-348, 2004.
  9. Hoshi Y*: NIRS imaging. In: Nakada T. ed., Integrated human brain science: theory, method, application (music). Elsevier Science, Amsterdam, pp239-247, 2000.
  10. Hoshi Y*, Eda H, Hazeki O, Nomura Y, Kakihana Y, Tamura M: Redox behabior of copper A in cytochrome oxidase in the brain in vivo: its clinical significance. In: Ishimura, Y., Shimada, H., Suematsu, M. eds., Oxygen homeostasis and its dynamics, Keio university symposia for life science and medicine, Springer-Verlag, Tokyo, pp84-97, 1998.
  11. Tamura M*, Hoshi Y, Hazeki O, Okada F: Cerebral oxygenation states as revealed by near-infrared spectrophotometry. In: Villringer A, Dirnagl U eds., Optical imaging of brain and metabolism II. Plenum Press, NY USA, pp91-96, 1997.
 

著書(和文)

  1. 星詳子*: 第4章6節,第5章1節・2節3項・3節, 第6章1節・4節.星詳子, 山田幸生(監修)生体ひかりイメージング 基礎と応用, エヌ・ティ-・エス, pp273-275, 285-293, 329-330, 341-343,351-352, 395-402, 2021.
  2. 星詳子*. 光脳機能イメージング. 武田勝彦, 三村將, 渡邉修(編) 高次脳機能障害のrehabilitation vre.3, 医歯薬出版株式会社, p172, 2018.
  3. 星詳子*:第2章,第3章,第7章.徳野博信(編)脳のイメージング.ブレインサイエンス・レクチャー3, 共立出版, pp19-38, 134-162, 2016.
  4. 星詳子*:光トポグラフィ 原理と基礎. 飛松省三(編)ここが知りたい!!臨床神経生理, 中外医学社,pp198-200, 2016.
  5. 星詳子*: NIRSと脳機能イメージング. 日本小児神経学会教育委員会(編)小児神経学の進歩 第44集,診断と治療社,pp51-63, 2015.
  6. 星詳子*:ダイナミック・マルチレベル生体光イメージングの可能性. 技術予測レポート2023(上)健康寿命の延伸を目指す日本の技術編. ソレカラ社(編)株式会社日本能率協会総合研究所,pp129-142, 2013.
  7. 星詳子*: 神経血管カップリング, 実験デザイン, NIRS信号のゆらぎ解析, NIRSデータの統計解析ツールボックスは可能か?統合失調症の前頭葉機能. 酒谷薫(監修)NIRS-基礎と臨床-. 新興医学出版社, pp29-34, pp29-34, pp45-54, pp82-85, pp.103-107, pp164-168, 2012.
  8. 星詳子*: NIRSを用いた小児の発達の解析.五十嵐隆, 久保田雅也(編),小児科臨床ピクシス ここまでわかった小児の発達. 中山書店, pp132-135, 2010.
  9. 星詳子*: 酸素代謝を利用した脳機能イメージング.酸素ダイナミクス研究会(編), からだと酸素の事典. 朝倉書店, pp438-445,2009.
  10. 星詳子*: 近赤外線スペクトロスコピー. 樋口輝彦,神庭重信,染矢俊幸,宮岡等(編), KEY WORD 精神 第4版.先端医学社, pp50-51, 2007.
  11. 星詳子*: 光イメージング法の将来と他のモダリティ(光イメージング法の将来).小川誠二, 上野照剛 (編), 非侵襲・可視化技術ハンドブック-ナノ・バイオ・医療から情報システムまで-.エヌ・ティ-・エス,pp356-360,2007.
  12. 星詳子*: 光イメージング法の将来と他のモダリティ(マルチモダリティ計測).小川誠二, 上野照剛(編), 非侵襲・可視化技術ハンドブック-ナノ・バイオ・医療から情報システムまで-.エヌ・ティ-・エス,pp350-355,2007.
  13. 星詳子*: 近赤外線脳機能イメージング. 高倉公朋, 菊池晴彦(編), 先端医療シリーズ16:機能的脳神経外科の最先端. 脳機能の局在診断. 先端医療技術研究, pp279-303,2002.
  14. 星詳子*: 機能的近赤外分光法. 片山容一, 酒谷薫(編)臨床医のため近赤外分光法.新興医学出版, pp107-114, 2002.
  15. 星詳子*: 近赤外線脳機能イメージング. 高倉公朋, 菊池晴彦(編), 先端医療シリーズ16:機能的脳神経外科の最先端. 脳機能の局在診断. 先端医療技術研究 pp279-303, 2002.
  16. 星詳子*: 近赤外光の医療への応用. 田村守(編)シリーズ光が拓く生命科学 第6巻:光による医学診断, 共立出版, pp97-110, 2001.
  17. 田村 守*, 野村保友, 星詳子, 根本正史: 光学技術を用いた脳機能計測.高田明和, 加藤 武, 中原大一郎, 野村正彦(編), 脳の動態をみる記憶とその障害の分子機構. 医学書院, pp134-150, 2001.
 
 

《研究業績目録》客員教授 尾花 明

学術論文(原著)

  1. Asaoka R, Nakakura S, Mochizuki T, Ishida A, Fujino Y, Ishii K, Obana A, Tanito M, Kiuchi Y.
    Which is More Effective and Safer? Comparison of Propensity Score-Matched Microhook Ab Interno Trabeculotomy and iStent Inject. Ophthalmol Ther. 2023 Oct;12(5):2757-2768. doi: 10.1007/s40123-023-00777-y. Epub 2023 Aug 7. PMID: 37548906
  2. Obana A, Asaoka R, Takayanagi Y, Gohto Y. Inter-device concordance of Veggie Meter-A reflection spectroscopy to measure skin carotenoids. J Biophotonics. 2023 Aug;16(8):e202300071. doi: 10.1002/jbio.202300071. Epub 2023 May 3. PMID: 37072378
  3. Tomita R, Asaoka R, Hirasawa K, Fujino Y, Nakakura S, Murata H, Omura T, Shoji N, Obana A, Nishiguchi KM, Tanito M. Accuracy of pattern deviation in estimating the glaucomatous damage in the central 10° visual field in eyes with glaucoma and cataract. Br J Ophthalmol. 2022 Oct 19:bjo-2022-322274. doi: 10.1136/bjo-2022-322274. Online ahead of print. PMID: 36261260
  4. Asaoka R, Obana A, Murata H, Fujino Y, Omoto T, Aoki S, Muto S, Takayanagi Y, Inoue T, Tanito M. The Association Between Age and Systemic Variables and the Longitudinal Trend of 1Intraocular Pressure in a Large-Scale Health Examination Cohort. Invest Ophthalmol Vis Sci. 2022 Oct 3;63(11):22. doi: 10.1167/iovs.63.11.22. PMID: 36301531
  5. Obana A, Asaoka R, Miura A, Nozue M, Takayanagi Y, Nakamura M. Improving Skin Carotenoid Levels in Young Students through Brief Dietary Education Using the Veggie Meter.
    Antioxidants (Basel). 2022 Aug 14;11(8):1570. doi: 10.3390/antiox11081570. PMID: 36009289
  6. Yamane Y, Mochiji M, Ichioka S, Takayanagi Y, Ishida A, Obana A, Tanito M. Effects of water chestnut (Tarpa bispinosa Roxb.) extract/lutein on fingertip-measured advanced glycation endproduct/carotenoid levels.Free Radic Res. 2022 Mar-Apr;56(3-4):282-289. doi: 10.1080/10715762.2022.2085098. Epub 2022 Jun 10. PMID: 35687659
  7. Takayanagi Y, Obana A, Muto S, Asaoka R, Tanito M, Ermakov IV, Bernstein PS, Gellermann W. Relationships between Skin Carotenoid Levels and Metabolic Syndrome.Antioxidants (Basel). 2021 Dec 22;11(1):14. doi: 10.3390/antiox11010014. PMID: 35052521
  8. Obana A, Gohto Y, Asaoka R, Gellermann W, Bernstein PS. Lutein and Zeaxanthin Distribution in the Healthy Macula and Its Association with Various Demographic Factors Examined in Pseudophakic Eyes. Antioxidants (Basel). 2021 Nov 23;10(12):1857. doi: 10.3390/antiox10121857. PMID: 34942960
  9. Ohishi K, Hosono K, Obana A, Noda A, Hiramitsu T, Hotta Y, Minoshima S. Identification of susceptibility loci for light-induced visual impairment in rats. Exp Eye Res. 2021 Sep;210:108688. doi: 10.1016/j.exer.2021.108688. Epub 2021 Jul 5. PMID: 34237304
  10. Tomoto K, Fujimoto A, Inenaga C, Okanishi T, Imai S, Ogai M, Fukunaga A, Nakamura H, Sato K, Obana A, Masui T, Arai Y, Enoki H. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility. BMC Neurol. 2021 Mar 31;21(1):139. doi: 10.1186/s12883-021-02160-5. PMID: 33784976
  11. Obana A, Gohto Y, Asaoka R. Macular pigment changes after cataract surgery with yellow-tinted intraocular lens implantation. PLoS One. 2021 Mar 25;16(3):e0248506. doi: 10.1371/journal.pone.0248506. eCollection 2021. PMID: 33764992
  12. Ishii K, Asaoka R, Omoto T, Mitaki S, Fujino Y, Murata H, Onoda K, Nagai A, Yamaguchi S, Obana A, Tanito M. Predicting intraocular pressure using systemic variables or fundus photography with deep learning in a health examination cohort. Sci Rep. 2021 Feb 11;11(1):3687. doi: 10.1038/s41598-020-80839-4. PMID: 33574359
  13. Obana A, Ote K, Hashimoto F, Asaoka R, Gohto Y, Okazaki S, Yamada H. Correction for the Influence of Cataract on Macular Pigment Measurement by Autofluorescence Technique Using Deep Learning.Transl Vis Sci Technol. 2021 Feb 5;10(2):18. doi: 10.1167/tvst.10.2.18. PMID: 34003903
  14. Takayanagi Y, Yamanaka M, Fujihara J, Matsuoka Y, Gohto Y, Obana A, Tanito M. Evaluation of Relevance between Advanced Glycation End Products and Diabetic Retinopathy Stages Using Skin Autofluorescence. Antioxidants (Basel). 2020 Nov 9;9(11):1100. doi: 10.3390/antiox9111100. PMID: 33182320
  15. Obana A, Nakazawa R, Noma S, Sasano H, Gohto Y. Macular Pigment in Eyes With Macular Hole Formation and Its Change After Surgery. Transl Vis Sci Technol. 2020 Oct 26;9(11):28. doi: 10.1167/tvst.9.11.28. eCollection 2020 Oct. PMID: 33173607
  16. Shirakami T, Yamanaka M, Fujihara J, Matsuoka Y, Gohto Y, Obana A, Tanito M. Advanced Glycation End Product Accumulation in Subjects with Open-Angle Glaucoma with and without Exfoliation. Antioxidants (Basel). 2020 Aug 15;9(8):755. doi: 10.3390/antiox9080755. PMID: 32824189
  17. Tanabe H, Obana A, Yamamoto S, Ichikumi K, Gohto Y, Seto T, Moriyama T. Potential roles of MNREAD acuity charts and contrast/glare sensitivity in Ranibizumab treatment of branch retinal vein occlusion. PLoS One. 2020 Jul 10;15(7):e0235897. doi: 10.1371/journal.pone.0235897. eCollection 2020. PMID: 32649680
  18. Obana A, Gohto Y, Nakazawa R, Moriyama T, Gellermann W, Bernstein PS. Effect of an antioxidant supplement containing high dose lutein and zeaxanthin on macular pigment and skin carotenoid levels. Sci Rep. 2020 Jun 24;10(1):10262. doi: 10.1038/s41598-020-66962-2. PMID: 32581313
  19. Obana A, Gohto Y, Sasano H, Gellermann W, Sharifzadeh M, Seto T, Bernstein PS. Spatial distribution of macular pigment estimated by autofluorescence imaging in elderly Japanese individuals. Jpn J Ophthalmol. 2020 Mar;64(2):160-170. doi: 10.1007/s10384-020-00716-5. Epub 2020 Jan 27. PMID: 31989400
  20. Obana A, Gohto Y, Gellermann W, Ermakov IV, Sasano H, Seto T, Bernstein PS. Skin Carotenoid Index in a large Japanese population sample. Sci Rep. 2019 Jun 27;9(1):9318. doi: 10.1038/s41598-019-45751-6. PMID: 31249340
  21. Kato A, Obana A, Gohto Y, Seto T, Sasano H. Optic coherence tomography appearances of retinal astrocytic hamartoma and systemic features in tuberous sclerosis of Japanese patients. Eur J Ophthalmol. 2019 May;29(3):330-337. doi: 10.1177/1120672118787441. Epub 2018 Jul 11. PMID: 29991284
  22. Fujimoto A, Okanishi T, Imai S, Ogai M, Fukunaga A, Nakamura H, Sato K, Obana A, Masui T, Arai Y, Enoki H. Establishment of a Regional Interdisciplinary Medical System for Managing Patients with Tuberous Sclerosis Complex (TSC). Sci Rep. 2018 Nov 13;8(1):16747. doi: 10.1038/s41598-018-35168-y. PMID: 30425292
  23. Sueoka K, Chikama T, Pertiwi YD, Ko JA, Kiuchi Y, Sakaguchi T, Obana A. Antifungal efficacy of photodynamic therapy with TONS 504 for pathogenic filamentous fungi. Lasers Med Sci. 2019 Jun;34(4):743-747. doi: 10.1007/s10103-018-2654-y. Epub 2018 Oct 4. PMID: 30284654
  24. Sueoka K, Chikama T, Latief MA, Ko JA, Kiuchi Y, Sakaguchi T, Obana A. Time-dependent antimicrobial effect of photodynamic therapy with TONS 504 on Pseudomonas aeruginosa.
    Lasers Med Sci. 2018 Sep;33(7):1455-1460. doi: 10.1007/s10103-018-2490-0. Epub 2018 Mar 27. PMID: 29589177
  25. Obana A, Gohto Y, Moriyama T, Seto T, Sasano H, Okazaki S. Reliability of a commercially available heterochromatic flicker photometer, the MPS2, for measuring the macular pigment optical density of a Japanese population. Jpn J Ophthalmol. 2018 Jul;62(4):473-480. doi: 10.1007/s10384-018-0588-3. Epub 2018 Mar 28. PMID: 29594609
  26. Sasano H, Obana A, Sharifzadeh M, Bernstein PS, Okazaki S, Gohto Y, Seto T, Gellermann W.
    Optical Detection of Macular Pigment Formation in Premature Infants. Transl Vis Sci Technol.
    2018 Jul 9;7(4):3. doi: 10.1167/tvst.7.4.3. eCollection 2018 Jul. PMID: 30002950
  27. Obana A, Gohto Y, Sasano H, Gellermann W, Sharifzadeh M, Seto T, Bernstein PS. Grade of Cataract and Its Influence on Measurement of Macular Pigment Optical Density Using Autofluorescence Imaging. Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3011-3019. doi: 10.1167/iovs.17-23699. PMID: 30025122
  28. Ermakov IV, Ermakova M, Sharifzadeh M, Gorusupudi A, Farnsworth K, Bernstein PS, Stookey J, Evans J, Arana T, Tao-Lew L, Isman C, Clayton A, Obana A, Whigham L, Redelfs AH, Jahns L, Gellermann W. Optical assessment of skin carotenoid status as a biomarker of vegetable and fruit intake. Arch Biochem Biophys. 2018 May 15;646:46-54. doi: 10.1016/j.abb.2018.03.033. Epub 2018 Mar 27. PMID: 29601824
  29. Takei M, Obana A, Inomata T, Tanaka T, Shiang T, Bae Y, Takemura T, Murakami A. Fundus changes in type III membranoproliferative glomerulonephritis: a case report. BMC Ophthalmol. 2018 Mar 6;18(1):72. doi: 10.1186/s12886-018-0738-x. PMID: 29510686
  30. Obana A, Gellermann W, Gohto Y, Seto T, Sasano H, Tanito M, Okazaki S. Reliability of a two-wavelength autofluorescence technique by Heidelberg Spectralis to measure macular pigment optical density in Asian subjects. Exp Eye Res. 2018 Mar;168:100-106. doi: 10.1016/j.exer.2017.12.015. Epub 2018 Jan 20. PMID: 29357284
  31. Obana A, Sasano H, Okazaki S, Otsuki Y, Seto T, Gohto Y. Evidence of Carotenoid in Surgically Removed Lamellar Hole-Associated Epiretinal Proliferation. Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5157-5163. doi: 10.1167/iovs.17-22347. PMID: 29049715
  32. Yamashiro K, Mori K, Honda S, Kano M, Yanagi Y, Obana A, Sakurada Y, Sato T, Nagai Y, Hikichi T, Kataoka Y, Hara C, Koyama Y, Koizumi H, Yoshikawa M, Miyake M, Nakata I, Tsuchihashi T, Horie-Inoue K, Matsumiya W, Ogasawara M, Obata R, Yoneyama S, Matsumoto H, Ohnaka M, Kitamei H, Sayanagi K, Ooto S, Tamura H, Oishi A, Kabasawa S, Ueyama K, Miki A, Kondo N, Bessho H, Saito M, Takahashi H, Tan X, Azuma K, Kikushima W, Mukai R, Ohira A, Gomi F, Miyata K, Takahashi K, Kishi S, Iijima H, Sekiryu T, Iida T, Awata T, Inoue S, Yamada R, Matsuda F, Tsujikawa A, Negi A, Yoneya S, Iwata T, Yoshimura N. A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration. Sci Rep. 2017 Aug 23;7(1):9196. doi: 10.1038/s41598-017-09632-0. PMID: 28835685
  33. Yoshizako H, Hara K, Takai Y, Kaidzu S, Obana A, Ohira A. Comparison of macular pigment and serum lutein concentration changes between free lutein and lutein esters supplements in Japanese subjects. Acta Ophthalmol. 2016 Sep;94(6):e411-6. doi: 10.1111/aos.13106. Epub 2016 Jun 8. PMID: 27273910
  34. Obana A, Gohto Y, Seto T. Anti-vascular Endothelial Growth Factor Therapy on Exudative Age-related Macular Degeneration in Routine Clinical Practice of a Single Site: the Effectiveness of Cases Followed for More than Two Years. Nippon Ganka Gakkai Zasshi. 2016 Feb;120(2):91-100. PMID: 26987207
  35. Obana A, Tanito M, Gohto Y, Okazaki S, Gellermann W, Bernstein PS. Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements. PLoS One. 2015 Oct 9;10(10):e0139257. doi: 10.1371/journal.pone.0139257. eCollection 2015. PMID: 26451726
  36. Latief MA, Chikama T, Ko JA, Kiuchi Y, Sakaguchi T, Obana A. Inactivation of acyclovir-sensitive and -resistant strains of herpes simplex virus type 1 in vitro by photodynamic antimicrobial chemotherapy.Mol Vis. 2015 May 2;21:532-7. eCollection 2015. PMID: 25999680
  37. Latief MA, Chikama T, Shibasaki M, Sasaki T, Ko JA, Kiuchi Y, Sakaguchi T, Obana A. Antimicrobial action from a novel porphyrin derivative in photodynamic antimicrobial chemotherapy in vitro. Lasers Med Sci. 2015 Jan;30(1):383-7. doi: 10.1007/s10103-014-1681-6. Epub 2014 Oct 30. PMID: 25354754
  38. Obana A, Gohto Y, Tanito M, Okazaki S, Gellermann W, Bernstein PS, Ohira A. Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy.
    Graefes Arch Clin Exp Ophthalmol. 2014 Nov;252(11):1867. doi: 10.1007/s00417-014-2802-4. Epub 2014 Oct 9. PMID: 25298005
  39. Sharifzadeh M, Obana A, Gohto Y, Seto T, Gellermann W. Autofluorescence imaging of macular pigment: influence and correction of ocular media opacities. J Biomed Opt. 2014 Sep;19(9):96010. doi: 10.1117/1.JBO.19.9.096010. PMID: 25223707
  40. Obana A, Gohto Y, Tanito M, Okazaki S, Gellermann W, Bernstein PS, Ohira A. Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy.
    Graefes Arch Clin Exp Ophthalmol. 2014 Aug;252(8):1221-8. doi: 10.1007/s00417-014-2574-x. Epub 2014 Mar 11. PMID: 24614948
  41. Tanito M, Obana A, Gohto Y, Okazaki S, Gellermann W, Ohira A. Macular pigment density changes in Japanese individuals supplemented with lutein or zeaxanthin: quantification via resonance Raman spectrophotometry and autofluorescence imaging.Jpn J Ophthalmol. 2012 Sep;56(5):488-96. doi: 10.1007/s10384-012-0157-0. Epub 2012 Jun 15. PMID: 22699751
  42. Obana A, Tanito M, Gohto Y, Gellermann W, Okazaki S, Ohira A. Macular pigment changes in pseudophakic eyes quantified with resonance Raman spectroscopy. Ophthalmology. 2011 Sep;118(9):1852-8. doi: 10.1016/j.ophtha.2011.02.017. PMID: 21641040
  43. Obana A, Takahashi J, Ohnishi K, Shinohara H, Matsuo A, Saito I, Ohkawa T, Ono T. Survey of ocular injury by solar eclipse 2009. Nippon Ganka Gakkai Zasshi. 2011 Jul;115(7):589-94. PMID: 21815488
  44. Obana A, Brinkmann R, Gohto Y, Nishimura K. A case of retinal injury by a violet light-emitting diode. Retin Cases Brief Rep. 2011 Summer;5(3):223-6. doi: 10.1097/ICB.0b013e3181e180d5. PMID: 25390169
  45. Obana A, Gohto Y, Nishimura K. [Morphological changes in exudative age-related maculardegeneration afterphotodynamic therapy]. Nippon Ganka Gakkai Zasshi. 2008 Oct;112(10):863-75. PMID: 18949911
  46. Suzuki T, Inagaki K, Fukai K, Obana A, Lee ST, Tomita Y. A Korean case of oculocutaneous albinism type IV caused by a D157N mutation in the MATP gene. Br J Dermatol. 2005 Jan;152(1):174-5. doi: 10.1111/j.1365-2133.2005.06403.x. PMID: 15656822
  47. Obana A, Goto Y, Ikoma M. A case of von Hippel-Lindau disease with papillary capillary hemangioma treated by photodynamic therapy. Nippon Ganka Gakkai Zasshi. 2004 Apr;108(4):226-32. PMID: 15148739
  48. Huang Y, Obana A, Gohto Y, Nakajima S. Comparative study of the phototoxicity of two chrolin type photosensitizers, ATX-S10(Na) and verteporfin, on vascular endothelial and retinal pigment epithelial cells. Lasers Surg Med. 2004;34(3):216-26. doi: 10.1002/lsm.10251. PMID: 15022248
  49. Nagata S, Obana A, Gohto Y, Nakajima S. Necrotic and apoptotic cell death of human malignant melanoma cells following photodynamic therapy using an amphiphilic photosensitizer, ATX-S10(Na). Lasers Surg Med. 2003;33(1):64-70. doi: 10.1002/lsm.10190. PMID: 12866123
  50. Matsumoto M, Shiraki K, Obana A. Detection of choroidal neovascularization by subtraction indocyanine green angiography. Osaka City Med J. 2003 Dec;49(2):85-91. PMID: 15179837
  51. Obana A, Gohto Y. Scanning laser system for photodynamic therapy of choroidal neovascularization. Lasers Surg Med. 2002;30(5):370-5. doi: 10.1002/lsm.10056. PMID: 12116330
  52. Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion. Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2639-45. PMID: 11581211
  53. Gohto Y, Obana A, Kanai M, Nagata S, Nakajima S, Miki T. Treatment parameters for selective occlusion of experimental corneal neovascularization by photodynamic therapy using a water soluble photosensitizer, ATX-S10(Na). Exp Eye Res. 2001 Jan;72(1):13-22. doi: 10.1006/exer.2000.0931. PMID: 11133178
  54. Obana A, Gohto Y, Nishiguchi K, Miki T, Nishi S, Asada A. A retrospective pilot study of indocyanine green enhanced diode laser photocoagulation for subfoveal choroidal neovascularization associated with age-related macular degeneration.
    Jpn J Ophthalmol. 2000 Nov-Dec;44(6):668-76. doi: 10.1016/s0021-5155(00)00274-4. PMID: 11094185
  55. Obana A, Gohto Y, Ueda N, Miki T, Cho A, Suzuki Y. Retinal and subhyaloid hemorrhage as a complication of laser iridectomy for primary angle-closure glaucoma. Arch Ophthalmol. 2000 Oct;118(10):1449-51. PMID: 11030835
  56. Mori M, Kuroda T, Obana A, Sakata I, Hirano T, Nakajima S, Hikida M, Kumagai T. In vitro plasma protein binding and cellular uptake of ATX-S10(Na), a hydrophilic chlorin photosensitizer. Jpn J Cancer Res. 2000 Aug;91(8):845-52. doi: 10.1111/j.1349-7006.2000.tb01023.x. PMID: 10965027
  57. Mori M, Sakata I, Hirano T, Obana A, Nakajima S, Hikida M, Kumagai T. Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser. Jpn J Cancer Res. 2000 Jul;91(7):753-9. doi: 10.1111/j.1349-7006.2000.tb01009.x. PMID: 10920284
  58. Gohto Y, Obana A, Kaneda K, Nakajima S, Takemura T, Miki T. Accumulation of photosensitizer ATX-S10 (Na) in experimental corneal neovascularization.Jpn J Ophthalmol. 2000 Jul-Aug;44(4):348-53. doi: 10.1016/s0021-5155(00)00178-7. PMID: 10974289
  59. Suzuki Y, Obana A, Gohto Y, Miki T, Otuka H, Inoue Y. Management of orbital lymphangioma using intralesional injection of OK-432.Br J Ophthalmol. 2000 Jun;84(6):614-7. doi: 10.1136/bjo.84.6.614. PMID: 10837387
  60. Obana A, Gohto Y, Kanai M, Nakajima S, Kaneda K, Miki T. Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys. Arch Ophthalmol. 2000 May;118(5):650-8. doi: 10.1001/archopht.118.5.650. PMID: 10815157
  61. Obana A, Cho A, Takamine Y, Gohto Y, Miki T. A case of glaucoma with choroidal hemangioma managed by nonpenetrating trabeculectomy. Jpn J Ophthalmol. 2000 Mar-Apr;44(2):174-7. doi: 10.1016/s0021-5155(99)00192-6. PMID: 10715387
  62. Kanai M, Obana A, Gohto Y, Nagata S, Miki T, Kaneda K, Nakajima S. Long-term effectiveness of photodynamic therapy by using a hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats. Lasers Surg Med. 2000;26(1):48-57. doi: 10.1002/(sici)1096-9101(2000)26:1<48::aid-lsm8>3.0.co;2-z. PMID: 10637003
  63. Gohto Y, Obana A, Kanai M, Nagata S, Miki T, Nakajima S. Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na).Ophthalmic Surg Lasers. 2000 Jan-Feb;31(1):55-60. PMID: 10976562
  64. Obana A, Gohto Y, Kaneda K, Nakajima S, Takemura T, Miki T. Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.
    Lasers Surg Med. 1999;24(3):209-22. doi: 10.1002/(sici)1096-9101(1999)24:3<209::aid-lsm6>3.0.co;2-l. PMID: 10229152
  65. Obana A, Gohto Y, Matsumoto M, Miki T, Nishiguti K. Indocyanine green angiographic features prognostic of visual outcome in the natural course of patients with age related macular degeneration. Br J Ophthalmol. 1999 Apr;83(4):429-37. doi: 10.1136/bjo.83.4.429. PMID: 10434865
  66. Gohto Y, Obana A, Kaneda K, Nakajima S, Takemura T, Miki T. [Accumulation of a photosensitizer ATX-S 10 Na (II) to experimental corneal neovascularization].Nippon Ganka Gakkai Zasshi. 1998 Nov;102(11):724-30. PMID: 9852716
  67. Gohto Y, Obana A, Kaneda K, Miki T. Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization. Exp Eye Res. 1998 Sep;67(3):313-22. doi: 10.1006/exer.1998.0527. PMID: 9778412
  68. Obana A, Kusumi M, Miki T. Indocyanine green angiographic aspects of multiple evanescent white dot syndrome. Retina. 1996;16(2):97-104. doi: 10.1097/00006982-199616020-00002. PMID: 8724951
  69. Miki T, Shiraki K, Kohno T, Moriwaki M, Obana A. Computer assisted image analysis using the subtraction method in indocyanine green angiography. Eur J Ophthalmol. 1996 Jan-Mar;6(1):30-8. doi: 10.1177/112067219600600108. PMID: 8744848
  70. Obana A, Kusumi M, Moriwaki M, Yamaguchi M, Miki T. Two cases of multiple evanescent white dot syndrome examined with indocyanine green angiography. Nippon Ganka Gakkai Zasshi. 1995 Feb;99(2):244-51. PMID: 7701999
  71. Obana A, Miki T, Hayashi K, Takeda M, Kawamura A, Mutoh T, Harino S, Fukushima I, Komatsu H, Takaku Y, et al. Survey of complications of indocyanine green angiography in Japan. Am J Ophthalmol. 1994 Dec 15;118(6):749-53. doi: 10.1016/s0002-9394(14)72554-1. PMID: 7977601
  72. Obana A, Miki T, Matsumoto M, Ohtsuka H, Moriwaki M, Kamo M, Mii T, Kijima M. [An experimental and clinical study of chorioretinal photocoagulation using a frequency-doubled Nd: YAG laser]. Nippon Ganka Gakkai Zasshi. 1993 Sep;97(9):1040-6. PMID: 8213362
  73. Obana A, Lorenz B, Birngruber R. Transscleral and indirect ophthalmoscope diode laser retinal photocoagulation: experimental quantification of the therapeutic range for their application in the treatment of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 1993 Jul;231(7):378-83. doi: 10.1007/BF00919644. PMID: 8406062
  74. Obana A, Matsumoto M, Miki T, Eckert KG, Birngruber R, Gabel VP. Quantification of indocyanine-green enhancement of diode laser photocoagulation. Nippon Ganka Gakkai Zasshi. 1993 May;97(5):581-6. PMID: 8337962
  75. Matsumoto M, Miki T, Obana A, Shiraki K, Suh JH. Indocyanine green enhanced photocoagulation in the pigmented rabbit. Nippon Ganka Gakkai Zasshi. 1992 Jun;96(6):742-8. PMID: 1626476
  76. Suh JH, Miki T, Obana A, Shiraki K, Matsumoto M. Effects of indocyanine green dye enhanced diode laser photocoagulation in non-pigmented rabbit eyes. Osaka City Med J. 1991 Nov;37(2):89-106. PMID: 1792069
  77. Obana A, Miki T. Dye laser photocoagulation through experimentally induced retinal hemorrhage.
    Lasers Surg Med. 1991;11(2):152-7. doi: 10.1002/lsm.1900110209. PMID: 2034012
  78. Miki T, Inoue K, Obana A, Shiraki K. Possibility of choriocapillary occlusion under experimental subretinal hemorrhage by photocoagulation with lasers of different wavelengths.Lasers Surg Med. 1989;9(6):543-55. doi: 10.1002/lsm.1900090604. PMID: 2601548
  79. Obana A, Miki T. [The effect of melanin and hemoglobin on the dye laser photocoagulation in pigmented and albino rabbits]. Nippon Ganka Gakkai Zasshi. 1989 Aug;93(8):844-51. PMID: 2610165
  80. Obana A, Miki T, Inoue K, Shiraki K. Retino-choroidal changes with dye laser photocoagulation in experimental subretinal hemorrhage. Nippon Ganka Gakkai Zasshi. 1988 Jan;92(1):90-7. PMID: 3389266
  81. Obana A, Shiraki K, Sugino K, Miki T. Experimental study on the retinal tear. 6. Observation on retinal vessels around the retinal tear by trypsin digestion method. Nippon Ganka Gakkai Zasshi. 1986 Jun;90(6):888-97. PMID: 3751791
 
 
  • facebookでshareできます
  • twitterでshareできます
  • lineでshareできます